Evidence map›Paper›PMID 38250061›Full record

ReviewFrontiers in immunology2023

The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.

Saverio La Bella, Armando Di Ludovico, Giulia Di Donato, Ozge Basaran, Seza Ozen, Marco Gattorno, Francesco Chiarelli, Luciana Breda

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. PYRIN mActa pharmacologica Sinica · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Saverio La BellaDepartment of Pediatrics, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Armando Di LudovicoDepartment of Pediatrics, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Giulia Di DonatoDepartment of Pediatrics, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Ozge BasaranDepartment of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Seza OzenDepartment of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Marco GattornoUOC Rheumatology and Autoinflammatory Diseases, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Francesco ChiarelliDepartment of Pediatrics, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Luciana BredaDepartment of Pediatrics, "G. D'Annunzio" University of Chieti, Chieti, Italy.
University of Chieti-Pescara · ITHacettepe University · TRIstituto Giannina Gaslini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The activation of the pyrin inflammasome represents a highly intriguing mechanism employed by the innate immune system to effectively counteract pathogenic agents. Despite its key role in innate immunity, pyrin has also garnered significant attention due to its association with a range of autoinflammatory diseases (AIDs) including familial Mediterranean fever caused by disruption of the

Indexed as

Familial Mediterranean FeverInflammasomesPyrinAutoimmune DiseasesChildHumansImmunity, InnateInflammationInflammasomesMEFV protein, humanPyrinautoinflammatory diseasesfamilial Mediterranean feverFMFgasdermin DIL-1inflammasomepyrin

Identifiers

PMID38250061
PMCPMC10796709
OpenAlexW4390610311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.